Proove Genomics is a predictive healthcare and personalized medical diagnostics company. Our predict and prevent approach to precision medicine is supported by the world's largest clinical data bank, which includes data from over 153,000 pain patients and encompasses 28 billion clinical outcome data points. Proove conducts laboratory testing that utilizes advanced information technology and mathematical algorithms in its CLIA-certified laboratory, coupled with a patient’s phenotypic factors such as age, gender, and ethnicity, we enhance the treatment of pain and other ailments for improved patient quality of life. Our research has been published in peer-reviewed journals and recognized by leading medical societies such as the American Academy of Pain Medicine, American Society of Interventional Pain Physicians, American Academy of Neurology, American Society of Regional Anesthesia, American Academy of Addiction Medicine, and more. Proove operates a state-of-the-art CLIA-certified laboratory in the Dallas-Forth Worth Metroplex. Proove is also opening offices in southern California, the Baltimore-Washington metropolitan area, and the Salt Lake City metropolitan area.